Ocean Biomedical, Inc. (NASDAQ:OCEAW) Short Interest Update

Ocean Biomedical, Inc. (NASDAQ:OCEAW) saw a large drop in short interest in the month of February. As of February 15th, there was short interest totalling 15,100 shares, a drop of 52.8% from the January 31st total of 32,000 shares. Based on an average daily volume of 70,200 shares, the days-to-cover ratio is presently 0.2 days.

Ocean Biomedical Stock Down 7.8 %

Shares of OCEAW stock traded down $0.00 during trading hours on Friday, reaching $0.03. 25,861 shares of the company traded hands, compared to its average volume of 100,407. The firm has a 50-day moving average price of $0.03 and a 200 day moving average price of $0.04. Ocean Biomedical has a 12-month low of $0.02 and a 12-month high of $0.70.

About Ocean Biomedical

Ocean Biomedical, Inc, a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The company is developing mono-specific and bi-specific humanized monoclonal antibodies (mAb) product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.